Clinical Trial Update: Decitabine Based Chemotherapy Followed by Haploidentical Lymphocyte Infusion for Elderly Patients With AML [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating decitabine-based chemotherapy followed by haploidentical lymphocyte infusion in elderly AML patients has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• decitabine-based chemotherapy (decitabine)
• haploidentical lymphocyte infusion (haploidentical lymphocyte infusion)

Snippet

Sponsor: Chinese PLA General Hospital | Conditions: AML | Phase 2 | Status: COMPLETED